• Главная
• О журнале
• Редакционная коллегия
• Подписка
• Правила оформления статей
• Порядок рецензирования статей
• Архив выпусков
• Наши авторы
• Статьи
  • По алфавиту
  • По категориям
• Блоги и комментарии



---

Адрес редакции
355017, Ставрополь, улица Мира, 310.

Телефоны
(8652) 35-25-11, 35-32-29.

E-mail
medvestnik@stgmu.ru

Журнал включён в Перечень ведущих рецензируемых научных журналов и изданий, в которых должны быть опубликованы результаты диссертаций на соискание учёной степени кандидата и доктора наук (решение Президиума ВАК Минобрнауки РФ №6/6, февраль 2010).

Журнал включён в Реферативный журнал и Базы данных ВИНИТИ РАН и зарегистрирован в Научной электронной библиотеке в базе данных Российского индекса научного цитирования на основании сублицензионного договора № 07-04/09-14 от 25 марта 2009 года.

Журнал индексируется: БД SCOPUS, Ulrich's International Periodicals Directory.

EBSCO

https://doi.org/10.14300/mnnc.2014.09111

Эстрогенные гормоны и эндотелиальная дисфункция Сообщение 1. Эстрогены и метаболический синдром

[Обзоры]
Арушанян Эдуард Бениаминович;

описание

Скачать

Список литературы:
1. Alemany, M. Do the interactions between glucocorticoids and sex hormones regulate the development of the metabolic syndrome? / M. Alemany // Front. Endocrinol. – 2012. – Vol. 3. – P. 27–35.
2. Bader, M. I. Comparative assessment of estrogenic responses with relevance to the metabolic syndrome and to menopausal symptosm in wild-type and aromataseknockout mice / M. I. Dader, J. Wober, G. Krezschmar [et al.] // J. Steroid. Biochem. Mol. Biol. – 2011. – Vol. 127. – P. 428–434.
3. Banerjee, A. Regulation of leptic synthesis in white adipose tissue of the female fruit bat: role of melatonin with or without insulin / A. Banerjee, S. Usdin, A. Krishna // Exp. Physiol. – 2011. – Vol. 96. – P. 216– 225.
4. Banos, G. Sex steroid hormones, cardiovascular diseases and the metabolic syndrome / G. Banos, V. Guarner, I. Perez-Torrs // Cardiovasc. Hematol. Agents Med. Chem. – 2011. – Vol. 9. – P. 137–146.
5. Barros, R. P. Estrogen receptors and the metabolic network / R. P. Barros, J. Gustafsson // Cell. Metab. – 2011. – Vol. 14. – P. 289–299.
6. Beltowski, J. Adiponectin and resistin – new hormones of white adipose tissue / J. Beltowski // Med. Sci. Monit. – 2003. – Vol. 9. – P. RA55–RA61.
7. Behloul, N. Genestein: a promising therapeutic agent for obesity and diabetes / N. Behloul, G. Wu // Eur. J. Pharmacol. – 2013. – Vol. 698. – P. 31–38.
8. Bhattacharya, S. The control of hypoglycemia by estrol and progesterone in alloxan– induced type 1 diabetes mellitus mice model through hepatic insulin / S. Bhattacharya, S. Bank, S. Maiti // Int. J. Biomed. Sci. – 2014. – Vol.10. – P. 8–15.
9. Butera, P. C. Estradiol and the control of food intake / P. C. Butera // Physiol. Behav. – 2010. – Vol. 99. – P. 175–180.
10. Cassanova, G. Effect of nonoral estradiol-micronized progesterone or low-dose oral estradiol-drospitenone therapy on metabolic variables and markers of endothelial function in early postmenopause / G. Cassanova, S. Radavelli, F. Lhuter // Fertil. Steril. – 2009. – Vol. 92. – P. 605–612.
11. Cicero, A. F. Metabolic syndrome, adipokines and hormonal factors in pharmacologically untreated adult elderly subjects from the Brisighella Heart Study historical cohort / A. F. Cicero, P. Magni, M. More [et al.] // Obes. Facts – 2012. – Vol. 5. – P. 319–326.
12. Cuadros, J. L. Body mass index and its correlation to metabolic and hormone parameters in postmenopausal Spanish women / J. L. Cuadros, A. M. Fernandez Alonso, A. M. Cuadros [et al.] // Gynecol. Endocrinol. – 2011. – Vol. 27. – P. 678 684.
13. Davis, S. R. Differing effects of low-dose estrogenprogestin therapy and parvastatin in postmenopausal hypercholesterolemic women / S. R. Davis, R. Golstadt, A. Newman [et al.] // Climacteric. – 2002. – Vol. 5. – P. 341–350.
14. Davis, K. E. The sexually dimorphic role of adipose and adipocyte estrogen receptors in modulating adipose tissue expansion, inflammation, and fibrosis / K. E. Davis, M. Neinast, K. Sun [et al.] // Mol. Metab. – 2013. – Vol. 2. – P. 227–242.
15. De Arauja, L. F. Effect of conjugated equine estrogens and tamoxifen administration on thyroid gland histomorphology of the rats / L. F. De Arauja, J. M. Soares, R. S. Simoes [et al.] // Clinics (San Paolo). – 2006. – Vol. 61. – P. 321–326.
16. De Franciscis, P. Low-dose estrogen and drospirenone combination: effects on metabolism and endothelial function in postmenopausal women with metabolic syndrome / P. De Franciscis, G. Minini, D. Labriola [et al.] // – 2013. – Vol. 40. – P. 233–235.
17. Ding, E. L. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis / E. L. Ding, Y. Song, V. S. Malik // JAMA. – 2006. – Vol. 295. – P. 1288–1299.
18. Fallah, S. Adiponectin, leptin and lipid profiles evaluation in oral contraceptive pill consumers / S. Fallah, M. Sanjary Pour, A. Rabbani Chadegani // Arch. Gynecol. Obstet. – 2012. – Vol. 285. – P. 1747–1752.
19. Foryst-Ludwig, A. Metabolic impact of estrogen signaling through ERalpha and ERbeta / A. Foryst-Ludwig, U. Kinscher // J. Steroid. Biochem. Mol. Biol. –2010. – Vol. 122. – P. 74–81.
20. Fuente-Martin, E. Estrogen, astrocytes and the neuroendocrine control of metabolism / E. Fuente- Martin, C. Grcia-Cacers, E. Morselli [et al.] // Rev. Endocrin. Metab. Disord. – 2013. – Vol.14. – P. 331-338.
21. Gracia, C. R. Thyroid function during controlled ovarian hyperstimulation as part of in vitro fertilization / C. R. Gracia, C. B. Morse, G. Chan [et al.] // Fertil. Steril. – 2012. – Vol. 97. – P. 585–591.
22. Guarner-Lans, V. Relation of aging and sex hormones to metabolic syndrome and cardiovascular disease / V. Guarner-Lans, M. E. Rubrio-Ruiz, J. Perez-Torres // Exp. Gerontol. – 2011. – Vol. 46. – P. 517–523.
23. Irace, C. Genistein and endothelial function in postmenopausal women with metabolic syndrome / C. Irace, H. Marini, A. Bitto [et al.] // Eur. J. Clin. Invest. – 2013. – Vol. 43. – P. 1025–1031.
24. Jequier, E. Leptin signaling, adiposity, and energy balance / E. Jequier // Ann. N.Y. Acad. Sci. – 2002. – Vol. 967. – P. 379–388.
25. Jungbauer, A. Phytoestrogens and the metabolic syndrome / A. Jungbauer, S. Medjakovic // J. Steroid. Biochem. Mol. Biol. – 2014. – Vol. 139. – P. 277–289.
26. Kaaja, R. J. Metabolic syndrome and the menopause / R. J. Kaaja // Menopause Int. – 2008. – Vol. 14. – P. 21–25.
27. Kafkas, S. Effect of estrogen therapy on adipocytokines in ovariectomized-aged rats / S. Kafkas, T. Dost, H. Ozkayran [et al.] // J. Obstet. Gynecol. Res. – 2012. – Vol. 38. – P. 231–238.
28. Kim, J. Y. 17beta-estradiol induces an interaction between adenosine monophosphate-activated protein kinase and the insulin signaling pathway in 3T3 L1 adipocytes / J. Y. Kim, K. J. Jo, B. J. Kim [et al.] // Int. J. Mol. Med. – 2012. – Vol. 30. – P. 979–985.
29. Kim, M. J. Protective effect of short-term genistein supplementation on the early stage in diabetes-induced renal damage / M. J. Kim, Y. Lam // Mediators Inflamm. – 2013. – Vol. 20. – P. 51–62.
30. Kitagawa, A. Melatonin improves metabolic syndrome induced by high fructose intake in rats / A. Kitagawa, Y. Ohta, K. Ohashi // J. Pineal Res. – 2012. – Vol. 52. – P. 403–413.
31. Kus, I. Effects of estradiol benzoate on the ultrastructure of the pinealocyte in the ovariectomized rat / I. Kus, H. Oner, C. Ozogul [et al.] // Neuro Endocrinol. Lett. – 2002. – Vol. 23. – P. 405–410.
32. McInnes, K. J. Association of 17beta-hydroxystreroid dehydrogenase type 1 expression and activity with estrogen receptor beta in adipose tissue from postmenopausal women / K. J. Mclnnes, T. C. Andersson, K. Simonyte [et al.] // Menopause. – 2012. – Vol. 19. – P. 1347–1352.
33. Matsuzawa, Y. The metabolic syndrome and adipocytokines / Y. Matsuzawa // FEBS Lett. – 2006. – Vol. 580. – P. 2917–2921.
34. Mattsson, C. Estrogens and glucocorticoid hormones in adipose tissue metabolism / C. Mattsson, T. Olsson // Curr. Med. Chem. – 2007. – Vol. 14. – P. 2918–2924.
35. Merlotti, C. Prevention of type 2 diabetes: a systematic review and meta analysis of different intervention strategies / C. Merlotti, A. Morabito, A. E. Pontiroli // Diabetes Obes. Metab. – 2014. – Vol. 29. – P. 111–118.
36. Murase, T. Effects of estrogen on cardiovascular injury in ovariectomized female DahlS.Z.-Lepr (fa)/Lepr(fa) rats as a new animal model of metabolic syndrome / T. Murase, T. Hattori, M. Ohtake [et al.] // Hypertension. – 2012. – Vol. 59. – P. 694–704.
37. Nadkarni, S. Oestrogen and immunomodulation: new mechanisms that impact on peripheral and central immunity / S. Nadkarni, S. McArthur // Curr. Opin. Phrmacol. – 2013. – Vol. 13. – P. 576–581.
38. Narasimhan, A. Estradiol favors glucose oxidation in gastrocnemius muscle through modulation of insulin signaling molecules in adult female rts / A. Narasimhan, S. Sampath, S. Javaraman // Endocrinol. Res. – 2013. – Vol. 38. – P. 251–263.
39. Niwa, T. Effect of the genistein metabolite on leptin secretion in murine adipocytes in vitro / T. Niwa, S. Yokoyama, T. Osawa // Food Chem. – 2013. – Vol. 138. – P. 122–125.
40. Ortiz, J. B. Cholesterol and perhaps estradiol protect against corticosterone-induced hippocampal CA3 dendritic retraction in gondectomized female and male rats / J. B. Ortiz, K. J. McLaughlin, G. F. Hamilton [et al.] // Neuroscience. – 2013. – Vol. 246. – P. 409–421.
41. Sanchez-Mateos, S. Melatonin and estradiol effects on food intake, body weight, and leptin in ovariectomized rats / S. Sanchez-Mateos, C. Alonso Gonzalez, A. Gonzalez [et al.] // Maturitas. – 2007. – Vol. 58. – Р. 91–101.
42. Santin, A. P. Validation of reference genes for normalizing gene expression in real time quantitative reverse transcription PCR in human thyroid cells in primary culture treated with progesterone and estradiol / A. P. Santin, A. F. Souza, L. D. Brum // Mol. Biotechnol. – 2013. – Vol. 54. – P. 278–282.
43. Santollo, J. Midde-aged female rats retain sensitivity to the anorexigenic effect of exogenous estradiol / J. Santollo, D. Yao, G. Neal-Perry // Behav. Brain Res. – 2012. – Vol. 232. – P. 159–164.
44. Schneider, J. G. The metabolic syndrome in women / J. G. Schneider, C. Tompkins, R. S. Blumenthal // Cardiol. Rev. – 2006. – Vol.14. – P. 286–291.
45. Shaw, K. A. Effect of a combined estrogen and progesterone oral contraceptive on circulating adipocytokines adiponectin, resistin and DLK-1 in normal and obese female rhesus monkeys / K. A. Shaw, J. D. Henneboid, A. B. Edelman // Contraception. – 2013. – Vol. 88. – P. 177–182.
46. Shi, H. G protein-coupled estrogen receptor in energy homeostasis and obesity pathogenesis / H. Shi. S. P. Kumar, X. Liu // Prog. Mol. Biol. Transl. Sci. – 2013. – Vol. 114. – P. 193–250.
47. Squadrito, E. Genstein in the metabolic syndrome: results of a randomized clinical trial / E. Squadrito, H. Me-rini, A. Bitto [et al.] // J. Clin. Endocrinol. Metab. – 2013. – Vol. 98. – P. 3366–3374.
48. Stubbins, R. E. Estrogen modulates abdominal adiposity and protects female mice from obesity and impaired glucose tolerance / R. E. Stubbins, V. B. Holcomb, J. Hong // Eur. J. Nutr. – 2012. – Vol. 51. – P. 861–870.
49. Tahboub, R. Sex steroids and the thyroid / R. Tahboub, B. M. Arafah // Best. Pract. Res. Clin. Endocrinol. Metab. – 2009. – Vol. 23. – P. 769–780.
50. Van Sinderen, M. L. Hepatic glucose intolerance precedes hepatic steatosis in the male aromatase knockout (ArKO) mouse / M. L. Van Sinderen, G. R. Steinberg, S. B. Jorgensen [et al.] // PLoS One. – 2014. – Vol. 9. – P. e87230.
51. Velickovic, K. Expression and subcellular localization of estrogen receptor receptors alpha and beta in human fetal brown adipose tissue / K. Velickovic, A. Cvoro, B. Srdic [et al.] // J. Clin. Endocrinol. Metab. – 2014. – Vol. 99. – P. 151 159.
52. Whirledge, S. Estradiol antagonism of glucocorticoid-induced GILZ expression in human uterine epithelial and murine uterus / S. Whirledge, J. A. Cidlowski // Endocrinology. – 2013. – Vol. 154. – P. 499–510.
53. Yamatani, H. Association of estrogen with glucocorticoid levels in visceral fat in postmenopausal women / H. Yamatani, K. Takahashi, T. Yoshida [et al.] // Menopause. – 2013. – Vol. 20. – P. 437–442.
54. Yanagisawa, M. Genistein and daidzen, typical soy isoflavones, inhibit TNF alpha-mediated downregulation of adiponectin expression via different mechanisms in 3T3- L1 adipocytes / M. Yanagisawa, M. Sugiya, H. Lijima [et al.] // Mol. Nutr. Food Res. – 2012. – Vol. 56. – P. 1783– 1793.
55. Zhu, L. Estrogen treatment after ovariectomy protects against fatty liver and may improve pathway-selective insulin resistance / L. Zhu, W. C. Brown, Q. Cai [et al.] // Diabetes. – 2013. – Vol. 62. – P. 424–434.
56. Zoth, N. Metabolic effects of estrogen substitution in combination with exercise training on the therapy of obesity in ovariectomized Wistar rats / N. Zoth, C. Weigt, S. Zengin [et al.] // J. Steroid. Biochem. Mol. Biol. – 2012. – Vol. 130. – P. 64–72.